Zobrazeno 1 - 10
of 617
pro vyhledávání: '"Scheele, W."'
Autor:
Delrue, Charlotte1 (AUTHOR) charlotte.delrue@ugent.be, Speeckaert, Reinhart2 (AUTHOR) reinhart.speeckaert@ugent.be, Moresco, Rafael Noal3 (AUTHOR) rnmoresco@ufsm.br, Speeckaert, Marijn M.1,4 (AUTHOR) marijn.speeckaert@ugent.be
Publikováno v:
International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9441. 21p.
Autor:
Gale JD; Inflammation and Immunology Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA., Gilbert S; Early Clinical Development, Pfizer Inc, Cambridge, Massachusetts, USA., Blumenthal S; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Elliott T; BC Diabetes, Vancouver, British Columbia, Canada., Pergola PE; Renal Associates PA, San Antonio, Texas, USA., Goteti K; Early Clinical Development, Pfizer Inc, Cambridge, Massachusetts, USA., Scheele W; Clinical Development and Operations, Pfizer Inc, Cambridge, Massachusetts, USA., Perros-Huguet C; Inflammation and Immunology Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA.
Publikováno v:
Kidney international reports [Kidney Int Rep] 2018 Aug 03; Vol. 3 (6), pp. 1316-1327. Date of Electronic Publication: 2018 Aug 03 (Print Publication: 2018).
Autor:
Ciechanowska, Agata1 (AUTHOR) ciechan@if-pan.krakow.pl, Mika, Joanna1 (AUTHOR) joamika@if-pan.krakow.pl
Publikováno v:
International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p3788. 43p.
Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy.
Autor:
Scheele W; Pfizer Inc., Cambridge, Massachusetts; wim.scheele@pfizer.com., Diamond S; San Antonio Kidney Disease Center, San Antonio, Texas., Gale J; Pfizer Inc., Cambridge, Massachusetts., Clerin V; Pfizer Inc., Cambridge, Massachusetts., Tamimi N; Pfizer Ltd., Sandwich, United Kingdom., Le V; Pfizer Inc., Cambridge, Massachusetts., Walley R; Pfizer Ltd., Sandwich, United Kingdom., Grover-Páez F; Institute of Experimental and Clinical Therapeutics, Universidad de Guadalajara, Guadalajara, México; and., Perros-Huguet C; Pfizer Inc., Cambridge, Massachusetts., Rolph T; Pfizer Inc., Cambridge, Massachusetts., El Nahas M; Sheffield Kidney Institute, Sheffield, United Kingdom.
Publikováno v:
Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2016 Nov; Vol. 27 (11), pp. 3459-3468. Date of Electronic Publication: 2016 Apr 25.
Autor:
Scheele, W., Timm, Th.
Publikováno v:
Kolloid Zeitschrift; Jun1951, Vol. 122 Issue 3, p129-134, 6p
Autor:
Scheele, W., Timm, Th.
Publikováno v:
Kolloid Zeitschrift; Mar1951, Vol. 121 Issue 3, p140-143, 4p
Autor:
Scheele, W., Timm, Th.
Publikováno v:
Kolloid Zeitschrift; Mar1951, Vol. 121 Issue 3, p144-147, 4p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
American Journal of Obstetrics & Gynecology; Mar2000, Vol. 182 Issue 3, p568-574, 7p
A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium.
Publikováno v:
Obstetrics & Gynecology; 2000 Jan, Vol. 95 Issue 1, p95-103, 9p